Combined Treatment Provides Benefit for Nasopharyngeal Cancer

Among patients with Stage II nasopharyngeal cancer (a type of head and neck cancer), adding chemotherapy to radiation therapy resulted in better survival than radiation therapy alone. These results were published in the Journal of the National Cancer Institute. The … Continue reading →

Study Suggests B Vitamin and Omega-3 Fatty Acid Supplements Don’t Reduce Cancer Risk

Among people with a history of cardiovascular disease, taking dietary supplements of B vitamins and/or omega-3 fatty acids does not appear to reduce the risk of cancer. These results were published in the Archives of Internal Medicine. Dietary supplements are … Continue reading →

Lynch Syndrome Also Linked with Breast and Pancreatic Cancer

A study of families with Lynch Syndrome has expanded the list of cancers related to the condition: carriers of a Lynch Syndrome gene mutation also appear to have an increased risk of breast cancer and pancreatic cancer. These results were … Continue reading →

Combination of Campath and Fludarabine Provides Benefit in CLL

Among people with previously treated, relapsed or refractory chronic lymphocytic leukemia (CLL), treatment with a combination of Campath® (alemtuzumab) and fludarabine results in better outcomes than treatment with fludarabine alone. These results were published in Lancet Oncology. Chronic lymphocytic leukemia … Continue reading →

Aggressive Rectal Cancer More Common in Young Adults

Signet cell rectal cancer—an aggressive type of rectal cancer—is almost five times more common in patients under the age of 40 than in older patients. These results were presented at the 97th Annual Clinical Congress of theAmericanCollege of Surgeons. The … Continue reading →

Juvenile Arthritis Linked with Higher Cancer Risk

Children with juvenile idiopathic arthritis (JIA) have a higher risk of cancer than children without JIA. The increased risk does not appear to be due to arthritis medications, but additional research is warranted. These results were published in Arthritis and … Continue reading →

Two Different Approaches to Rituxan Both Effective For Follicular Lymphoma

Among patients with low-tumor-burden follicular lymphoma who have received initial treatment with Rituxan® (rituximab), waiting until disease progression to take additional Rituxan is as effective as ongoing, maintenance Rituxan. These results were presented at the 53rd Annual meeting of the … Continue reading →

Chemotherapy Alone Effective for Hodgkin’s Lymphoma

Among patients with Stage IA or IIA nonbulky Hodgkin’s lymphoma, treatment with chemotherapy alone resulted in better overall survival than treatment that included radiation therapy. These results were published in the New England Journal of Medicine. Hodgkin’s lymphoma is a … Continue reading →

Breast Cancer Outcomes Vary By Age Among Postmenopausal Women

Among postmenopausal women with hormone receptor-positive breast cancer, the likelihood of dying from breast cancer increases with age. These results were published in the Journal of the American Medical Association. Of the more than 200,000 cases of breast cancer diagnosed … Continue reading →

Many Doctors Report Screening for Ovarian Cancer

Despite evidence to the contrary, one in three US physicians who offer primary care to women believe that ovarian cancer screening is effective. These results were published in the Annals of Internal Medicine. Roughly 70% of ovarian cancers are diagnosed … Continue reading →